APOL1 and pancreatic adenocarcinoma: Recent studies indicated that APOL1 exhibited oncogenic effects in PAAD, inhibiting PAAD cell apoptosis and promoting tumor cell proliferation through activation of the NOTCH1 signaling pathway (45), which was the first study reporting APOL1 function in PAAD.